Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 22, 2026, 1:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–1 of 1 matching trial from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: AXIN1 Gene Mutation Clear all

Terminated Phase 2 Interventional

A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation

NCT06005974

View directory record Official record

Conditions: AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor
Interventions: REC-4881; Drug
Lead sponsor: Recursion Pharmaceuticals Inc.; Industry
Eligibility: 55 Years and older

Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 13
States / cities: San Diego, California • Santa Barbara, California • Denver, Colorado + 10 more

Source: ClinicalTrials.gov public record

Updated Feb 22, 2026 · Synced May 22, 2026, 1:37 AM EDT